DKP Critical Insights® Syndicated Reports

DKP has developed a series of syndicated reports to provide perspectives into the oncology and rare-disease environment. The reports are designed to help you inform short- and long-term strategies that will support market positioning of your portfolio, as well as ongoing patient access to care.

Medicaid PBM Influence on Oncology
  • Identify key PBM relationships with Fee-for-Service Medicaid agencies
  • Outline the role and influence of key PBMs illustrating where they may impact new drug coverage and positioning, prior authorization development, drug purchasing pool oversight, and supplemental rebate solicitation
Click here for more information

We'd love to help you. Give us a call at (317) 873-0303.

Send us a message
  • This field is for validation purposes and should be left unchanged.